Wed, November 27, 2024

[ Wed, Nov 27th 2024 ]: Thomas Matters

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

[ Wed, Nov 27th 2024 ]: Thomas Matters

JPMorgan Sees US Equities Extending Global Dominance in 2025

[ Wed, Nov 27th 2024 ]: Thomas Matters

NTPC Green Energy Share Price Highlights: Stock e .. at 2.25 apiece on NSE, 2.27% premium to IPO price

[ Wed, Nov 27th 2024 ]: Thomas Matters

Money blog: Halifax goes rogue with new mortgage term

[ Wed, Nov 27th 2024 ]: Thomas Matters

Donald Trump Assumes Office in Fewer Than 60 Days .. vestors Expect Something Big From These 3 Stocks.

[ Wed, Nov 27th 2024 ]: Thomas Matters

Want $97 in Super-Safe Monthly Dividend Income? Invest $5,000 in These 3 Ultra-High-Yield Stocks

[ Wed, Nov 27th 2024 ]: Thomas Matters

Billionaire Warren Buffett Has Invested $9 Billion (at Cost) in These 2 Unstoppable Stocks

[ Wed, Nov 27th 2024 ]: Thomas Matters

Americans' stock-market optimism hits record high. But there are risks.

[ Wed, Nov 27th 2024 ]: Thomas Matters

Is Nvidia Still the Best Artificial Intelligence (AI) Stock to Own for 2025?

[ Wed, Nov 27th 2024 ]: Thomas Matters

JPMorgan Strategists See US Equities Extending Global Dominance

[ Wed, Nov 27th 2024 ]: Thomas Matters

Plug Power Highlights Green Hydrogen at Energy Conference

[ Wed, Nov 27th 2024 ]: Thomas Matters

The Best Small-Cap ETF to Buy Right Now (and One Intriguing Alternative)

[ Wed, Nov 27th 2024 ]: Thomas Matters

Money blog: World's most beautiful airports named

[ Wed, Nov 27th 2024 ]: Thomas Matters

Stocks rise Tuesday, Dow and S&P 500 close at records: Live updates

[ Wed, Nov 27th 2024 ]: Thomas Matters

Why we're continuing to add stocks and credit to portfolios in 2025

[ Wed, Nov 27th 2024 ]: Thomas Matters

Invesco American Franchise Fund Q3 2024 Commentary

[ Wed, Nov 27th 2024 ]: Thomas Matters

The Smartest Growth Stock to Buy With $3,000 Right Now

[ Wed, Nov 27th 2024 ]: Thomas Matters

E-Commerce Growth Is Back: 2 Smart Stocks to Buy

[ Wed, Nov 27th 2024 ]: Thomas Matters

FTSE 00 LIVE: Stocks slip as traders await US inflation data and mull Trump tariffs

[ Wed, Nov 27th 2024 ]: Thomas Matters

Four high-yield, high-promise small caps

[ Wed, Nov 27th 2024 ]: Thomas Matters

European Stocks Drop With Focus on ECB Rates, Trump Appointments

[ Wed, Nov 27th 2024 ]: Thomas Matters

Cathie Wood dumps millions of Palantir and Tesla stock; Here's what she bought

[ Wed, Nov 27th 2024 ]: Thomas Matters

Modi Wins Key State Elections, Instilling Confidence In The Indian Stock Market

[ Wed, Nov 27th 2024 ]: Thomas Matters

Money blog: UK pension scheme called 'deeply irresponsible' after investing in Bitcoin

[ Wed, Nov 27th 2024 ]: Thomas Matters

Tesla Stock And Trump: Risks Galore

[ Wed, Nov 27th 2024 ]: Thomas Matters

Money blog: UK pension scheme slammed for being 'deeply irresponsible' after investing in Bitcoin

[ Wed, Nov 27th 2024 ]: Thomas Matters

Stock market today: Wall Street hangs near its records despite tariff talk

[ Wed, Nov 27th 2024 ]: Thomas Matters

Investors cling to crash protection despite sizzling US stock market rally

[ Wed, Nov 27th 2024 ]: Thomas Matters

Stock market today: Wall Street hits records despite tariff talk

[ Wed, Nov 27th 2024 ]: Thomas Matters

Nvidia Aside: Top 5 AI Stocks to Buy in 2024 and Why

[ Wed, Nov 27th 2024 ]: Thomas Matters

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Tue, November 26, 2024

[ Tue, Nov 26th 2024 ]: Thomas Matters

Stocks Settle Higher on Positive Corporate News and Reduced Geopolitical Risks

[ Tue, Nov 26th 2024 ]: Thomas Matters

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

[ Tue, Nov 26th 2024 ]: Thomas Matters

Analysts Bullish on Reliance Comeback While Adani Stocks Remain Under Scrutiny

[ Tue, Nov 26th 2024 ]: Thomas Matters

HKDPB announces key findings of "Hongkongers' Sen .. Savings" Survey for the seventh consecutive year

[ Tue, Nov 26th 2024 ]: Thomas Matters

Enviro Infra Engineers IPO allotment likely today .. Check status, GMP, listing date and other details

[ Tue, Nov 26th 2024 ]: Thomas Matters

Nifty may retest its all-time high level. 3 stocks to lead the rally

[ Tue, Nov 26th 2024 ]: Thomas Matters

How to Invest in Intuitive Machines (LUNR)

[ Tue, Nov 26th 2024 ]: Thomas Matters

Trump Heralds Unease in Global Halls of Power With Tariff Threat

[ Tue, Nov 26th 2024 ]: Thomas Matters

2 No-Brainer Semiconductor Stocks to Buy Right Now

[ Tue, Nov 26th 2024 ]: Thomas Matters

Core portfolio with US equities could mitigate impact of looming 'seismic changes'

[ Tue, Nov 26th 2024 ]: Thomas Matters

Stock market today: S&P 500, Dow end at record as .. estors shake off tariff fears, digest Fed minutes

[ Tue, Nov 26th 2024 ]: Thomas Matters

Stock futures are little changed as Wall Street a .. s Fed's preferred inflation reading: Live updates

[ Tue, Nov 26th 2024 ]: Thomas Matters

Stock Market Today: The S&P 500 Reclaims the 6K Level

[ Tue, Nov 26th 2024 ]: Thomas Matters

Stock Market Today: Dow, S&P 500 end at records a .. inutes as investors shake off Trump tariff pledge

[ Tue, Nov 26th 2024 ]: Thomas Matters

Singapore-listed Dow ETF offers local investors a gateway to US stocks, say panellists

[ Tue, Nov 26th 2024 ]: Thomas Matters

Couche-Tard confident in persistent but friendly approach to bid for 7-Eleven owner

[ Tue, Nov 26th 2024 ]: Thomas Matters

Stock Market Highlights: Nifty short-term trend r .. trong resistance at 24,350. How to trade tomorrow

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank,
The article from MSN Money discusses why Catalyst Pharmaceutical (CPRX) is considered a strong momentum stock. It highlights that CPRX has shown significant positive momentum in its stock price, with a 1.86% increase last week, outperforming the Zacks Medical - Drugs industry which saw a 0.35% rise. Over longer periods, CPRX has also performed well, with a 13.86% increase in the last quarter and a 110.75% rise over the past year, compared to the S&P 500's 10.16% and 27.47% respectively. The stock's momentum is further supported by positive earnings estimate revisions; over the past two months, the consensus estimate for the full year has increased from $1.11 to $1.46. This upward trend in earnings estimates, combined with strong stock price performance, has led to CPRX receiving a Momentum Style Score of A and a Zacks Rank of #2 (Buy), making it an attractive option for investors looking for momentum stocks.

Read the Full MSN Article at [ https://www.msn.com/en-us/money/topstocks/here-s-why-catalyst-pharmaceutical-cprx-is-a-strong-momentum-stock/ar-AA1uRvLS ]